NCT05239793View on ClinicalTrials.gov

Electronic Cigarette-derived Oxidants and Cardiopulmonary Effects

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 22, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

NJOY e-cigarette

NJOY e-cigarette with Virginia Tobacco flavored 5% nicotine pods

Trial Locations (1)

17033

RECRUITING

Penn State Health Milton S. Hershey Medical Center, Hershey

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Milton S. Hershey Medical Center

OTHER